Trials / Unknown
UnknownNCT04912882
Prognosis Predicting of CRC Patients Based on Morphology and Molecular Biomaker of CTC
Prognosis Predicting of CRC Patients Based on Morphology and Molecular Biomaker of Circulating Tumor Cells
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- Fudan University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Detecting circulating tumor cells from I-IV stage colorectal cancer patients pre-and post-operatively. Analyzing the morphology and biomarkers of CTCs and builting prognosis predicting model based on the morphology and biomarkers of CTCs. Verifying the prognosis model by the survival data.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Circulating tumor cell | detecting circulating tumor cell pre- and post operatively |
Timeline
- Start date
- 2021-06-15
- Primary completion
- 2023-12-01
- Completion
- 2025-12-01
- First posted
- 2021-06-03
- Last updated
- 2021-06-03
Source: ClinicalTrials.gov record NCT04912882. Inclusion in this directory is not an endorsement.